This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through October 6, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
earnings-growth: Archive
Is Owens Corning (OC) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Owens Corning (OC) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
OCPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Consolidated Water (CWCO): Read This Before Placing a Bet
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Consolidated Water (CWCO) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
CWCOPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Nvidia (NVDA) Based on Wall Street's Bullish Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Nvidia (NVDA) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
NVDANegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts See SoundHound AI (SOUN) as a Buy: Should You Invest?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in SoundHound AI (SOUN). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
SOUNPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Comfort Systems (FIX) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Comfort Systems (FIX) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
FIXPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think QuickLogic (QUIK) Is a Good Investment: Is It?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), QuickLogic (QUIK) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
QUIKPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Should You Invest in Teradyne (TER) Based on Bullish Wall Street Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Teradyne (TER) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
TERPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think Badger Meter (BMI) Is a Good Investment: Is It?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Badger Meter (BMI) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
BMINegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think Energy Transfer LP (ET) Is a Good Investment: Is It?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Energy Transfer LP (ET) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
ETPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
3 Reasons Why Growth Investors Shouldn't Overlook New Gold (NGD)
by Zacks Equity Research
New Gold (NGD) could produce exceptional returns because of its solid growth attributes.
NGDNegative Net Change
earnings-growth growth-investing growth-investors growth-stocks
Is Enova International (ENVA) a Solid Growth Stock? 3 Reasons to Think "Yes"
by Zacks Equity Research
Enova International (ENVA) could produce exceptional returns because of its solid growth attributes.
ENVAPositive Net Change
earnings-growth growth-investing growth-investors growth-stocks
Looking for a Growth Stock? 3 Reasons Why RBC Bearings (RBC) is a Solid Choice
by Zacks Equity Research
RBC Bearings (RBC) is well positioned to outperform the market, as it exhibits above-average growth in financials.
RBCPositive Net Change
earnings-growth growth-investing growth-investors growth-stocks
Ollie's Bargain Outlet (OLLI) is an Incredible Growth Stock: 3 Reasons Why
by Zacks Equity Research
Ollie's Bargain Outlet (OLLI) could produce exceptional returns because of its solid growth attributes.
OLLINegative Net Change
earnings-growth growth-investing growth-investors growth-stocks
MTU Aero Engines (MTUAY) is an Incredible Growth Stock: 3 Reasons Why
by Zacks Equity Research
MTU Aero Engines (MTUAY) possesses solid growth attributes, which could help it handily outperform the market.
MTUAYNegative Net Change
earnings-growth growth-investing growth-investors growth-stocks
Is OneSpan (OSPN) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in OneSpan (OSPN). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
OSPNNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think Adma Biologics (ADMA) Is a Good Investment: Is It?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Adma Biologics (ADMA). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
ADMAPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Newmont (NEM) Based on Wall Street's Bullish Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Newmont (NEM) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
NEMNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Robinhood Markets (HOOD): Read This Before Placing a Bet
by Zacks Equity Research
The average brokerage recommendation (ABR) for Robinhood Markets (HOOD) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
HOODPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think Alibaba (BABA) Is a Good Investment: Is It?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Alibaba (BABA). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
BABANegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Ares Capital (ARCC) Based on Wall Street's Bullish Views?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Ares Capital (ARCC). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
ARCCPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About Star Bulk Carriers (SBLK): Should You Buy?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Star Bulk Carriers (SBLK) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
SBLKPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Chipotle (CMG) Based on Wall Street's Bullish Views?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Chipotle (CMG). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
CMGNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Spotify (SPOT) Based on Wall Street's Bullish Views?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Spotify (SPOT). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
SPOTNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is New Gold (NGD) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in New Gold (NGD). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
NGDNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
3 Reasons Growth Investors Will Love HCA (HCA)
by Zacks Equity Research
HCA (HCA) could produce exceptional returns because of its solid growth attributes.
HCANegative Net Change
earnings-growth growth-investing growth-investors growth-stocks